附表T -印度药品生产质量管理规范

Siddiqua Shaikh
{"title":"附表T -印度药品生产质量管理规范","authors":"Siddiqua Shaikh","doi":"10.52711/2231-5713.2022.00059","DOIUrl":null,"url":null,"abstract":"On June 23, 2000, the Government of India issued GSR No. 560(E) under Rule 157 of the Drugs and Cosmetic Rules, and on March 7, 2003, GSR No. 198(E) revised Good Manufacturing Practices (GMP). These rules were made necessary for all new ASU drug manufacturing facilities on June 23, 2000, and for existing units on June 23, 2002. (2 years grace period was given for existing ASU units to obtain GMP certification). The criteria for production premises and hygienic conditions are outlined in Schedule T. The fundamental goal of implementing Schedule-T was to ensure that producers maintained a consistent level of hygiene. Good manufacturing practises must be followed at all times. For all the manufacturers of ASU drugs. Compliance to Good manufacturing Practices is mandatory for all the manufacturers of ASU drugs.","PeriodicalId":8527,"journal":{"name":"Asian Journal of Pharmacy and Technology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Schedule T – Good Manufacturing Practice of Indian systems of medicine\",\"authors\":\"Siddiqua Shaikh\",\"doi\":\"10.52711/2231-5713.2022.00059\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"On June 23, 2000, the Government of India issued GSR No. 560(E) under Rule 157 of the Drugs and Cosmetic Rules, and on March 7, 2003, GSR No. 198(E) revised Good Manufacturing Practices (GMP). These rules were made necessary for all new ASU drug manufacturing facilities on June 23, 2000, and for existing units on June 23, 2002. (2 years grace period was given for existing ASU units to obtain GMP certification). The criteria for production premises and hygienic conditions are outlined in Schedule T. The fundamental goal of implementing Schedule-T was to ensure that producers maintained a consistent level of hygiene. Good manufacturing practises must be followed at all times. For all the manufacturers of ASU drugs. Compliance to Good manufacturing Practices is mandatory for all the manufacturers of ASU drugs.\",\"PeriodicalId\":8527,\"journal\":{\"name\":\"Asian Journal of Pharmacy and Technology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of Pharmacy and Technology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.52711/2231-5713.2022.00059\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmacy and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52711/2231-5713.2022.00059","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

2000年6月23日,印度政府根据药品和化妆品规则157发布了GSR No. 560(E),并于2003年3月7日发布了GSR No. 198(E)修订的良好生产规范(GMP)。从2000年6月23日起,所有新的亚利桑那州立大学药品生产设施和2002年6月23日的现有单位都必须遵守这些规则。(现有ASU单位获得GMP认证给予2年宽限期)。生产场所和卫生条件的标准列于附表t。执行附表t的基本目标是确保生产者保持一贯的卫生水平。任何时候都必须遵守良好的生产规范。给所有亚利桑那州立大学药品的生产商。所有ASU药品制造商都必须遵守良好生产规范。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Schedule T – Good Manufacturing Practice of Indian systems of medicine
On June 23, 2000, the Government of India issued GSR No. 560(E) under Rule 157 of the Drugs and Cosmetic Rules, and on March 7, 2003, GSR No. 198(E) revised Good Manufacturing Practices (GMP). These rules were made necessary for all new ASU drug manufacturing facilities on June 23, 2000, and for existing units on June 23, 2002. (2 years grace period was given for existing ASU units to obtain GMP certification). The criteria for production premises and hygienic conditions are outlined in Schedule T. The fundamental goal of implementing Schedule-T was to ensure that producers maintained a consistent level of hygiene. Good manufacturing practises must be followed at all times. For all the manufacturers of ASU drugs. Compliance to Good manufacturing Practices is mandatory for all the manufacturers of ASU drugs.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Review on Inflammation and its Pharmacotherapy Formulation and Evaluation of Butea monosperma (Lam.) Ointment Nanosuspension: A Novel Approach to Improve the Solubility, Bioavailability and Pharmacokinetics of Poorly Soluble Drugs Basics and Recent Advances in Peptide and Protein Drug Delivery Formulation and Evaluation of Simvastatin Nanoparticles
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1